Related Experiment Videos
A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis
Sandra W Leung1, Elzbieta H Wloga, Alejandro F Castro
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Oncogene
|March 17, 2004
Summary
Genetic background significantly impacts retinoblastoma (Rb)+/- mouse neuroendocrine tumors. The 129Sv strain promotes pituitary tumors, while C57BL/6 enhances anterior pituitary tumors, improving this cancer model.
Area of Science:
- Genetics
- Oncology
- Neuroendocrinology
Background:
- Retinoblastoma gene (Rb)+/- mice develop neuroendocrine tumors.
- Tumor development varies significantly across different mouse genetic backgrounds.
- Understanding genetic contributions is crucial for refining cancer models.
Purpose of the Study:
- To investigate how the 129Sv and C57BL/6 genetic backgrounds influence Rb+/- tumorigenesis.
- To analyze the pathological profiles of Rb+/- mice on distinct genetic backgrounds.
- To enhance the utility of the Rb+/- mouse model for studying pituitary tumors.
Main Methods:
- Serial backcrossing of Rb+/- mice to 129Sv and C57BL/6 strains.
- Pathological analysis of tumor development and progression.
- Comparative analysis of survival rates, tumor penetrance, severity, and multiplicity.
Main Results:
- The 129Sv background dramatically enhances the initiation and progression of intermediate lobe pituitary tumors (ILP) in Rb+/- mice.
- Wild-type 129Sv mouse ILPs are inherently abnormal and predisposed to neoplasia.
- Rb+/- mice on the C57BL/6 background develop high-penetrance anterior pituitary lobe tumors, mirroring human tumor incidence.
Conclusions:
- Genetic background is a critical determinant of Rb+/- neuroendocrine tumor spectrum and severity.
- The 129Sv strain's predisposition to ILP tumors explains high incidence in related knockout studies.
- The Rb+/- C57BL/6 model offers improved utility for studying anterior pituitary tumors relevant to human disease.